Liberty Media Corporation - Liberty Formula One Series B (OTCMKTS:FWONB) Stock Price Down 1.1% - Should You Sell?

Key Points

• Liberty Media Corporation - Liberty Formula One Series B's stock price decreased by 1.1%, closing at $90.00 after reaching a low of $90.00.
• The company's market capitalization stands at $22.45 billion with a price-to-earnings ratio of -225.00.
• In the most recent quarterly earnings report, Liberty Media reported $400 million in revenue and earnings per share of $0.05.

Liberty Media Corporation - Liberty Formula One Series B (OTCMKTS:FWONB - Get Free Report)'s share price dropped 1.1% on Tuesday . The company traded as low as $90.00 and last traded at $90.00. Approximately 100 shares changed hands during mid-day trading, an increase of 324% from the average daily volume of 24 shares. The stock had previously closed at $91.00.

Liberty Media Corporation - Liberty Formula One Series B Stock Down 1.1%

The firm has a market cap of $22.45 billion, a price-to-earnings ratio of -225.00 and a beta of 0.42. The business's fifty day moving average is $89.11 and its two-hundred day moving average is $83.81.

Liberty Media Corporation - Liberty Formula One Series B (OTCMKTS:FWONB - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.05 earnings per share for the quarter. The company had revenue of $400.00 million during the quarter.

Liberty Media Corporation - Liberty Formula One Series B Company Profile

Formula One Group, through its subsidiary Formula 1, engages in the motorsports business in the United States and internationally. The company holds commercial rights for the FIA Formula One world championship, approximately a nine-month long motor race-based competition in which teams compete for the constructors' championship and drivers compete for the drivers' championship.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.